Governance
Ethics & Sovereignty
Anti-Extraction Model. NomosLogic functions as clinical infrastructure, not a wellness application. All findings are supported by validated sources.
How We're Different
All findings are supported by ClinVar, PharmGKB, CPIC guidelines, and peer-reviewed literature with traceable publication identifiers. The platform resolves findings rather than predicting outcomes.
1. Deterministic, Not Predictive
The platform executes 1.26 million clinical rules against user data. Every result references published clinical guidelines or regulatory drug labeling — not statistical estimations. Medication contraindications cite specific FDA label language.
2. Data Sovereignty
Users maintain ownership of genomic profiles. Provider access requires explicit authorization that can be granted or revoked. Identity protection employs cryptographic hashing to separate demographic and genomic information.
3. Multi-Omic Integration
The system combines genetic data with laboratory biomarkers to identify findings invisible in single datasets — such as linking genetic cancer susceptibility variants to unexplained iron deficiency patterns.
4. Population-Calibrated Results
Genetic variant significance is calibrated using NIH All of Us Research Program and UK Biobank data (445,000+ participants), ensuring findings reflect individual biology rather than global population averages.
5. Audit Traceability
Every platform decision is logged with source, logic pathway, and triggering evidence. Clinical inquiries receive citation-based answers rather than confidence scores.